mhy 219.

Maprotiline-d3 is intended for use as an internal standard for the quantification of maprotiline by GC- or LC-MS. Maprotiline is a tricyclic antidepressant. It binds to the norepinephrine transporter (NET) and is selective for NET over the serotonin and dopamine transporters. Maprotiline also binds to the serotonin (5-HT) receptor subtype 5-HT2A, as well as histamine H1, muscarinic acetylcholine, α1-adrenergic, and dopamine D2 receptors. In vivo, maprotiline inhibits norepinephrine reuptake in rat brain and peripheral tissues. It reduces isolation-induced aggressive behavior and inhibits electrical foot-shock stimulation-induced belligerence in mice when administered at doses ranging from 3 to 10 mg/kg. Maprotiline also reduces aggressive behavior in rhesus monkeys housed in groups. Formulations containing maprotiline have been used in the treatment of depression and anxiety.

Maprotiline 能够抑制细胞的增殖和转移，具有抗癌作用。 Maprotiline 通过靶向 ERK 信号通路和 CRABP1 诱导癌细胞凋亡。 Maprotiline 是一种高度选择性的去甲肾上腺素再摄取阻滞剂，具有有效的抗抑郁作用 [1][2]。

Maprotiline-d5 Hydrochloride 是 Maprotiline Hydrochloride 的氘代化合物。Maprotiline Hydrochloride 的 CAS 号为 10347-81-6。Maprotiline hydrochloride 是一种桥环四环类抗抑郁药，是去甲肾上腺素重吸收抑制剂。

Maprotiline hydrochloride (Psymion) 是一种桥环四环类抗抑郁药，是去甲肾上腺素重吸收抑制剂。